Trial · NCT07883603
Autogenous and Xenograft Bone Mix in Alveolar Ridge Reconstruction
NCT07883603, Not applicable, Not yet recruiting, salah mohamed mohamed ibrahim ibrahim
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Autogenous and Xenograft Bone Mix in Alveolar Ridge Reconstruction. Trials, record NCT07883603. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07883603
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Autogenous and Xenograft Bone Mix in Alveolar Ridge Reconstruction
- NCT number
- NCT07883603
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 30 participants, estimated
- Lead sponsor
- salah mohamed mohamed ibrahim ibrahim
- Conditions
- Horizontal Alveolar Ridge Deficiency
- Interventions
- 25% Autogenous + 75% Xenograft, 50% Autogenous + 50% Xenograft
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Radiographic Horizontal Bone Gain | Baseline to 6 months postoperatively | The radiographic horizontal bone gain will be assessed by comparing the horizontal alveolar ridge width before guided bone regeneration and at 6 months postoperatively using standardized CBCT measurements at predetermined reference points. |
| Secondary | Clinical Horizontal Bone Gain | Baseline to 6 months postoperatively | Clinical horizontal bone gain will be assessed by measuring the alveolar ridge width at standardized reference points using a periodontal caliper before surgery and at 6 months postoperatively |
| Secondary | Quality of Bone | 6 months postoperatively, at implant placement | The quality of the regenerated bone will be evaluated histologically from a core biopsy obtained from the augmented site at the time of implant placement. Histological assessment will characterize the quality and composition of the regenerated bone |
| Secondary | Vertical Bone Gain | Baseline to 6 months postoperatively | Vertical bone gain will be assessed radiographically by comparing standardized CBCT measurements obtained before guided bone regeneration and at 6 months postoperatively. |
| Secondary | Keratinized Tissue Width | Baseline and 3 and 6 months after augmentation | The width of keratinized tissue will be measured clinically at standardized sites using a UNC-15 graduated periodontal probe at baseline and at 6 months postoperatively. |
| Secondary | Soft Tissue Thickness | Baseline and 3 and 6 months after augmentation | Soft tissue thickness will be measured at standardized sites using a needle with a stopper before treatment and at 6 months postoperatively. |
| Secondary | Incidence of Postoperative Infection | 1 week, 2 weeks, and 6 months after augmentation | The incidence of postoperative infection will be recorded based on the presence or absence of clinical signs of infection, including swelling, suppuration, pain, or other clinical findings requiring intervention or antibiotic treatment. |
| Secondary | Postoperative Edema | 1 week and 2 weeks after augmentation | Postoperative facial edema will be assessed using a flexible measuring thread at standardized facial reference points and recorded as the change in facial measurements following surgery |
| Secondary | Procedural Time | During the surgical procedure | The total procedural time will be measured from the beginning of the surgical procedure until completion of wound closure using a stopwatch. |
| Secondary | Postoperative Pain | Day 1 to Day 14 after augmentation | Patient-reported postoperative pain will be assessed using a Visual Analog Scale (VAS) during the postoperative follow-up period. |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07883603
GET https://conductscience.org/api/trials/v1/NCT07883603/registered